COMP <GO>
CROX vs AMZN // NET PROFIT MARGIN
Crocs Inc. (NASDAQ) VS. Amazon.com, Inc. (NASDAQ) • 15-METRIC TALLY: CROX 3
— AMZN 6
■ METRIC PARITY
LAST: $150.52 (+0.17%) • MKT CAP: $7.20B
net-margins
-2.00%
LAST: $240.35 (-1.41%) • MKT CAP: $2.59T
net-margins
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CROX VS. AMZN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CROX | AMZN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 58.30% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 4.90% | 17.61% | -12.71 | AMZN | /roic <GO> |
| EV/EBITDA & P/E Valuation | 43.0x | 15.8x | +27.25 | AMZN | /valuation <GO> |
| Free Cash Flow Yield | 9.15% | -1.81% | +10.96 | CROX | /fcf-yield <GO> |
| Operating Margin | 3.70% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin ACTIVE | -2.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | -1.50% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.81 | 3.32 | +0.49 | CROX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 6/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.00% | 6.73% | +0.27 | AMZN | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 77.8 | 38.3 | +39.49 | CROX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.04 | 1.46 | -0.42 | AMZN | /macro-sensitivity <GO> |
| Forward P/E Multiple | 32.0x | 22.8x | +9.25 | AMZN | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $7.20B | $2.59T | -$2.59T | AMZN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CROX REV | AMZN REV | CROX GROSS % | AMZN GROSS % | CROX FCF | AMZN FCF |
|---|---|---|---|---|---|---|
| FY 2026 | — | $0 | — | — | — | -$46.89B |
| FY 2025 | $4.04B | $0 | 58.3% | — | $659.2M | $10.56B |
| FY 2024 | $4.10B | $0 | 58.8% | — | $923.1M | $42.95B |
| FY 2023 | $3.96B | $0 | 44.0% | — | $752.1M | $16.92B |
| FY 2022 | — | $0 | — | — | — | -$26.32B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CROX // BETA 1.04
AMZN // BETA 1.46